NATIONAL INSTITUTES OF HEALTH
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
- Conditions
- Stage IV Prostate CancerAdenocarcinoma of the Prostate
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2014-12-18
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 55
- Registration Number
- NCT00666666
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
πΊπΈUniversity of Michigan, Ann Arbor, Michigan, United States
πΊπΈCancer Institute of New Jersey, New Brunswick, New Jersey, United States
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
- Conditions
- Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myelomonocytic Leukemia (M4)Childhood Acute Eosinophilic LeukemiaChildhood Acute Erythroleukemia (M6)
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 52
- Registration Number
- NCT00666588
- Locations
- πΊπΈ
University of Alabama at Birmingham, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
- Conditions
- Stage I Bladder CancerStage II Bladder CancerStage III Bladder Cancer
- Interventions
- Other: Laboratory Biomarker AnalysisDietary Supplement: Defined Green Tea Catechin ExtractOther: Pharmacological StudyDrug: PlaceboProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 31
- Registration Number
- NCT00666562
- Locations
- πΊπΈ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈLahey Hospital and Medical Center, Burlington, Massachusetts, United States
πΊπΈMinneapolis Veterans Medical Center, Minneapolis, Minnesota, United States
Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma
- First Posted Date
- 2008-04-24
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 10
- Registration Number
- NCT00665470
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Conditions
- Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
- Interventions
- Procedure: Diffusion Tensor ImagingProcedure: Diffusion Weighted ImagingProcedure: Dynamic Contrast-Enhanced Magnetic Resonance ImagingRadiation: Fludeoxyglucose F-18Radiation: Intensity-Modulated Radiation TherapyOther: Laboratory Biomarker AnalysisProcedure: Perfusion Magnetic Resonance ImagingProcedure: Positron Emission Tomography
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 46
- Registration Number
- NCT00662506
- Locations
- πΊπΈ
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
πΊπΈDana-Farber Cancer Institute, Boston, Massachusetts, United States
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
- Conditions
- Adult FibrosarcomaAdult LeiomyosarcomaAdult LiposarcomaAdult Malignant Fibrous HistiocytomaAdult RhabdomyosarcomaDermatofibrosarcoma ProtuberansEndometrial Stromal SarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Uterine SarcomaStage III Adult Soft Tissue Sarcoma
- Interventions
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 17
- Registration Number
- NCT00659360
- Locations
- πΊπΈ
Fox Chase Cancer Center, Rockledge, Pennsylvania, United States
π¨π¦Cross Cancer Institute, Edmonton, Alberta, Canada
π¨π¦University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
Hepatitis C Treatment and Atherosclerosis
- Conditions
- Chronic Hepatitis CAtherosclerosis
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2019-12-12
- Target Recruit Count
- 70
- Registration Number
- NCT00659256
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
- Conditions
- Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2AAdult Acute Myeloid Leukemia Without MaturationAdult Acute Megakaryoblastic LeukemiaAdult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11Adult Acute Monoblastic LeukemiaAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Pure Erythroid Leukemia
- Interventions
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 133
- Registration Number
- NCT00658814
- Locations
- πΊπΈ
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
πΊπΈStanford Cancer Institute Palo Alto, Palo Alto, California, United States
πΊπΈUniversity of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Follow-Up Study of Kidney Cancer Patients
- Conditions
- Renal Cancer
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 1002
- Registration Number
- NCT00656955
- Locations
- π¨πΏ
Dept of Cancer Epidemioology Genetics, Brno, CZ, Brno, Czechia
π¨πΏOlomouc University, Olomouc, Czechia
π΅π±National Institute of Occupational Medicine, Lodz, Poland, Lodz, Poland
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
- Conditions
- HIV InfectionsCardiovascular DiseaseInsulin ResistanceHIV LipodystrophyThe Metabolic Syndrome
- Interventions
- Behavioral: Exercise Training
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2013-08-28
- Target Recruit Count
- 24
- Registration Number
- NCT00656851
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States